Lecturer | Al-Mustaqbal University | Iraq
Dr. Alaa Hamza Abbas Sultan is a distinguished academic and researcher from Iraq, currently serving as Director of the Drugs and Forensic Poisons Information Center at Diwaniyah Health. He earned his Ph.D. and M.Sc. in Pharmacology from Al-Nahrain University, following a Bachelor of Pharmacy from Mosul University. His professional journey includes roles as a pharmacist, lecturer, certified trainer, and health administrator, contributing significantly to clinical pharmacology, medical education, and healthcare development. Dr. Abbas has been actively involved in reviewing for reputable journals and has participated in numerous international conferences, both as a researcher and reviewer. His research focuses on pharmacological interventions for metabolic disorders, inflammation, and dermatological conditions, with several impactful studies exploring the therapeutic effects of natural products and pharmacological agents, especially in models of hyperglycemia, hyperlipidemia, and psoriasis. Notable publications include articles in Naunyn-Schmiedeberg’s Archives of Pharmacology, ACS Pharmacology & Translational Science, and the Journal of Taibah University Medical Sciences. Beyond research, he contributes to teaching pharmacology, histology, and medical sciences, mentoring future professionals. His scholarly presence is recognized across Google Scholar, Scopus, ORCID, and Web of Science, reflecting his integration into the global scientific community. Dr. Abbas has authored 10 publications, which collectively received 165 citations from 48 documents, showcasing the relevance of his work. His contributions have earned him an h-index of 8, reflecting both productivity and citation impact in his field
Profiles: Scopus | Google Scholar | ORCID
Featured Publications
1. Salman, H. R., Alzubaidy, A. A., Abbas, A. H., & Mohammad, H. A. (2024). Attenuated effects of topical vinpocetine in an imiquimod-induced mouse model of psoriasis. Journal of Taibah University Medical Sciences, 19(1), 35–53. Cited by: 30
2. Hayder Ridha-Salman, D. M. H. S. A. M., Al-Zubaidy, A. A., & Abbas, A. H. (2024). The alleviative effects of canagliflozin on imiquimod-induced mouse model of psoriasis-like inflammation. Naunyn-Schmiedeberg’s Archives of Pharmacology, 398, 1–21. Cited by: 29*
3. Ridha-Salman, H., Shihab, E. M., Hasan, H. K., Abbas, A. H., Khorsheed, S. M., & others. (2024). Mitigative effects of topical norfloxacin on an imiquimod-induced murine model of psoriasis. ACS Pharmacology & Translational Science, 7(9), 2739–2754. Cited by: 29
4. Hayder Ridha-Salman, A. H. A. Q. A. Z., & Al-Zubaidy, A. A. (2023). The ameliorative effects of topical gemifloxacin alone or in combination with clobetasol propionate on imiquimod-induced model of psoriasis in mice. Naunyn-Schmiedeberg’s Archives of Pharmacology. Cited by: 28*
5. Abbas, A. H. (2023). The attenuated effects of Epagliflozin on imiquimod-induced model of psoriasis. Latin American Journal of Pharmacy, 42(Special Issue), 362–369. Cited by: 21